Hongjoon Ahn, MOTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 10346 Southam Ln, Oakton, VA 22124 Phone: 571-432-7220 |
Hongjoon Occupational Therapy Occupational Therapist Medicare: Medicare Enrolled Practice Location: 10346 Southam Ln, Oakton, VA 22124 Phone: 571-432-7220 |
Shannon Taylor, MOT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 10337 Emerald Rock Dr, Oakton, VA 22124 Phone: 804-370-8185 |
Constance R Kohler, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 10904 Watermill Ct, Oakton, VA 22124 Phone: 703-307-4305 |
Kim Tracz Lipp Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 11802 Cobb Hill Ct, Oakton, VA 22124 Phone: 703-344-6326 |
Mrs. Melissa Grant, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3137 Stratford Ct, Oakton, VA 22124 Phone: 703-865-5012 |
Cork Ot Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 10904 Watermill Ct, Oakton, VA 22124 Phone: 703-307-4305 |
News Archive
Countries experiencing outbreaks of H5N1 in poultry need to be aware that domestic ducks may have acquired an important role in the transmission of highly pathogenic H5N1 to other poultry and, possibly, to humans as well.
In overweight and obese people, fat often gets deposited in the midsection of the body. Large amounts of this belly fat can lead to unhealthy changes in a heart's function and size.
Lux Biosciences, Inc., a privately held biotechnology company focused on the development and commercialization of therapies for serious ophthalmic diseases, today announced that the company has closed a $50 million Series B venture financing. Participants in the funding were current investors in Lux Biosciences, HBM Bioventures, Novo A/S, Prospect Venture Partners and SV Life Sciences (SVLS), as well as SVLS' publicly traded fund, International Biotechnology Trust plc.
Researchers at Intermountain Medical Center in Salt Lake City believe that they have made a breakthrough connection between atrial fibrillation, a fairly common heart rhythm disorder, and Alzheimer's disease, the leading form of dementia among Americans.
Keryx Biopharmaceuticals, Inc., a biopharmaceutical company focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of life-threatening diseases, including cancer and renal disease (the "Company"), today announced its results for the fourth quarter and year ended December 31, 2009.
› Verified 3 days ago